Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Curi Bio

Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
From Curi Bio
Via Business Wire
Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research
From Curi Bio
Via Business Wire
Curi Bio, Genetox, and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay
From Curi Bio
Via Business Wire
Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research
From Curi Bio
Via Business Wire
Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science
From Curi Bio
Via Business Wire
Curi Bio Launches MantaReady™ iPSC-Derived Skeletal Muscle Myoblasts
From Curi Bio
Via Business Wire
Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Media
From Curi Bio
Via Business Wire
Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer
From Curi Bio
Via Business Wire
Forbes 30 Under 30 Recognizes Curi Bio Co-founder & CBO Elliot Fisher on 2023 List
From Curi Bio
Via Business Wire
Curi Bio Launches Mantarray™ Platform – 3D Engineered Muscle Tissues for Discovery of New Therapeutics
From Curi Bio
Via Business Wire
Curi Bio Acquires CarTox™ Technology from StemBioSys, Announces Launch of Nautilus™ Optical Mapping System
From Curi Bio
Via Business Wire
Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products
From Curi Bio
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.